Month: June 2020

SOUTH ORANGE, N.J., June 02, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Nephros, Inc. (Nasdaq: NEPH), a commercial-stage company that develops and sells high performance water purification products and pathogen detection systems to the medical and commercial markets, today announced that it will be presenting at the upcoming Virtual Summer Summit on Tuesday, June 9th at 10:55 AM ET. Andy Astor, COO & CFO of Nephros, will be giving the presentation and answering questions from investors.You can access the webcast presentation at the following link: HEREFor more information and to register to attend or request a 1/1 virtual call click: HERE  About NephrosNephros is a commercial-stage company that develops and markets high performance water purification products and pathogen detection systems for medical and commercial markets.Nephros...

CINCINNATI, June 02, 2020 (GLOBE NEWSWIRE) — Protech Home Medical Corp. (“Protech” or the “Company”) (TSXV: PTQ) (OTCQX: PTQQF), a healthcare services company with operations in the U.S., today announced that it has qualified to trade on the OTCQX® Best Market.The common shares of Protech will commence trading at the open today on OTCQX under the symbol “PTQQF.” U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.The OTCQX Best Market provides value and convenience to U.S. investors, brokers and institutions seeking to trade PTQQF. The OTCQX Best Market is OTC Markets Group’s premier market for established, investor-focused U.S. and international companies. Trading on the OTCQX Market is intended to offer companies efficient, cost-effective access to the U.S....

SOUTH SAN FRANCISCO, Calif., June 02, 2020 (GLOBE NEWSWIRE) — Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, today announced that the compensation committee of the company’s board of directors granted two new employees a non-qualified stock option to purchase an aggregate of 15,200 shares of Calithera’s common stock, at a per share exercise price of $5.82, the closing trading price on May 29, 2020. One-fourth of the options vest in May 2021, and the balance of the options vest in a series of thirty-six successive equal monthly installments thereafter and was granted pursuant to the Calithera Biosciences, Inc. 2018 Inducement Plan, or Inducement Plan, which was approved...

PRESS RELEASEGLOBAL GRAPHICS: NOTICE OF ANNUAL GENERAL MEETINGCambridge (UK) 2 June 2020: Global Graphics PLC (Euronext: GLOG) announces details of its Annual General Meeting.Notice is hereby given that the Annual General Meeting (“AGM”) of Global Graphics PLC (the “Company”) will be held by video conference on Thursday 25 June 2020 at 14:00 hrs (CEST).A copy of the notice, including explanatory notes, is available on the investors section of the Company’s web site at https://www.globalgraphics.com/investors/shareholders-annual-general-meeting.  The meeting notice and explanatory notes have also been mailed to the registered address of all registered shareholders.All proxy voting will be conducted electronically via the Company’s share registrar, Link Asset Services.  Details of which have been provided to registered shareholders.  For...

 Papendrecht, 2 June 2020Royal Boskalis Westminster N.V. (Boskalis) in consortium with Bouygues Travaux Publics (Bouygues) and Saipem has been awarded the design work, construction and installation scope for 71 concrete Gravity-Based Structures (GBS) as foundation for the Fécamp offshore wind farm in Normandy, France. The award was made by Eoliennes Offshore des Hautes Falaises (EOHF). The contract carries a total value of EUR 552 million and the contract value split being 40.5% (Bouygues Travaux Publics) 40.5% (Saipem) 19% (Boskalis).The offshore wind farm will be located between 13 and 22 kilometers off the coast of Fécamp in Normandy. The 71 wind turbines will be connected to the gravity-based foundations installed on the seabed at depths between 25 and 30 meters.Within the consortium, Bouygues, as the leader of the Consortium, and...

Papendrecht, 2 juni 2020Koninklijke Boskalis Westminster N.V. (Boskalis) heeft in consortium met Bouygues Travaux Publics (Bouygues) en Saipem het contract verworven voor het ontwerp, de bouw en de installatie van 71 betonnen Gravity-Based Structures (GBS) die als fundering dienen voor de turbines van het Fécamp offshore windpark in Normandië, Frankrijk. Het contract werd toegekend door Eoliennes Offshore des Hautes Falaises (EOHF). De totale contractwaarde bedraagt EUR 552 miljoen waarvan het aandeel Boskalis 19% is en Bouygues en Saipem ieder 40,5%.Het offshore windpark komt 13 tot 22 kilometer uit de kust van Fécamp in Normandië te liggen. De 71 windturbines worden verbonden met de GBS funderingen die worden geïnstalleerd op het zeebed op een diepte tussen 25 en 30 meter.Binnen het consortium zijn Bouygues, als penvoerder, en Saipem...

Selskabsmeddelelse nr. 11/2020Agat Ejendomme A/S, CVR-nr. 24256782, indkalder hermed til ordinær generalforsamling onsdag den 24. juni 2020 kl. 16.00 i Aalborg Kongres & Kultur Center, Gæstesalen, Europa Plads 4, 9000 Aalborg.Se vedhæftede dagsorden og de fuldstændige forslag.Kontaktdetaljer:Agat Ejendomme A/SAdm. direktør Robert AndersenTel.: +45 8896 1010Vedhæftet filNr._11_Indkaldelse_ordinær_generalforsamling

WAYNE, Pa., June 02, 2020 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the first patient enrollment in a clinical study that will evaluate the performance of Teleflex coronary guidewires and specialty catheters in Chronic Total Occlusion (CTO) percutaneous coronary intervention (PCI) procedures, which is currently an investigational indication for these products. Enrolling up to 150 patients across approximately 15 investigational sites in the US, the CTO-PCI Study is a prospective, single-arm IDE study employing the primary angiographic endpoint of successful (intralumenal) guidewire placement beyond the CTO.CTOs are longstanding complete blockages in coronary arteries that usually result in profound regional reduction of coronary blood flow (ischemia). Clinically...

STAMFORD, Conn., June 02, 2020 (GLOBE NEWSWIRE) — SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer, today announced that Saqib Islam, Chief Executive Officer, will present at the Goldman Sachs 41st Annual Global Healthcare Conference on Tuesday, June 9, 2020 at 8:50 a.m. Eastern Standard Time.A video webcast will be available live on the “Events & Presentations” page within the Investors & Media section of the company’s website at https://ir.springworkstx.com. A replay of the webcast will be available on SpringWorks’ website for approximately 30 days following the conference.About SpringWorks TherapeuticsSpringWorks is a clinical-stage biopharmaceutical company applying a precision medicine...